Successful management of a pregnant woman with COVID-19 and multiple severe complications.
Muhammad Ilham Aldika AkbarKhanisyah Erza GumilarBrahmana Askandar TjokroprawiroRenata Alya UlhaqPublished in: BMJ case reports (2021)
We report a case of a 36-year-old gravida 2 para 1 woman at 38 weeks of gestation. A caesarean section was performed for severe pre-eclampsia, intrauterine growth restriction and oligohydramnios. The patient suffered postoperative bleeding, and exploratory laparotomy was performed. Uterine atonia, Couvelaire uterus and left adnexal haematoma were found, requiring a supracervical hysterectomy. As COVID-19 pneumonia and superimposed bacterial infection developed, the patient was mechanically ventilated in the intensive care unit. Remdesivir and meropenem were initially administered, but were changed to levofloxacin and ciprofloxacin following antibiotic sensitivity tests. Blood culture grew Enterococcus galinarum Meanwhile, bleeding of the incisional wound occurred, which was controlled by the cessation of heparin therapy and regular wound care. With intensive monitoring and multidisciplinary management, the patient's condition improved, and she was discharged from the hospital on day 25 from admission.
Keyphrases
- case report
- coronavirus disease
- sars cov
- healthcare
- atrial fibrillation
- emergency department
- intensive care unit
- pseudomonas aeruginosa
- venous thromboembolism
- patients undergoing
- preterm infants
- risk factors
- stem cells
- pregnant women
- quality improvement
- acute respiratory distress syndrome
- surgical site infection
- mesenchymal stem cells
- drug induced
- electronic health record
- multidrug resistant
- escherichia coli
- cell therapy
- preterm birth
- replacement therapy
- extracorporeal membrane oxygenation